Lundbeck A/S, NeuroSearch A/S and Janssen Pharmaceutica NV will host a Kv7 Potassium Channel Symposium on the 28th and 29th September in Copenhagen, Denmark.

This symposium will bring together a multi-disciplinary group of researchers, clinicians, and drug discovery experts to build upon our knowledge and understanding of the Kv7 ion channel from molecular biology/physiology to clinical utility. The symposium will include plenary sessions, panel discussions, and opportunities for networking.

Participants will explore several focus areas, including:

• Electrophysiological and pharmacology properties of Kv7 ion channels
• Regional expression and modulation of neurotransmitter systems linked to psychiatric diseases
• Behavioural pharmacology
• Emerging therapeutic areas
• Future research directions